U.S. Stem Cell (USRM) 10-Q2014 Q1 Quarterly report

Filed: 9 May 14, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. sophomore Avg

New words: accrual, acquisition, Additionally, adult, advisor, arm, automatically, Beaumont, benchmark, Cassel, conference, consulting, CSC, Daniel, degeneration, degenerative, delay, deposit, disc, discontinue, disease, divided, driver, dry, entertainment, erectile, expand, Global, guidance, Hospital, human, imposed, Indiana, inducement, infrastructure, innovative, inside, instrument, IP, joint, kit, length, macular, mended, Mezzanine, Northwestern, notification, obstructive, pending, preclinical, profile, program, project, proliferation, promising, pulmonary, recapitalized, Regenestem, reimburse, renewed, rent, responsible, Salpeter, segment, sensitive, simulated, size, steady, thier, travel, twenty, University, variety, vary, vitro, WBH

Removed: achievement, add, Administration, advanced, affordable, age, AHA, al, Ambulatory, Amendment, animal, apply, assumption, attack, avoid, bound, capable, card, Cardiology, care, Chairman, charge, comfortable, commercial, commitment, committed, consecutive, constitute, contractile, corporate, daily, damaged, demonstrated, developed, diagnosed, Diastolic, die, differentiating, Diller, directly, discretion, Drug, dying, education, eighty, eleven, endoventricular, engrafted, engrafting, establish, European, exceeded, exceeding, exertion, faced, facility, FIFO, floor, Food, Force, Frequency, grown, guarantee, health, high, improve, Incorporation, incur, invasive, inventory, irrevocably, isolated, item, knowledge, leading, lease, legend, licensing, limitation, lipicell, lose, maintaining, manner, mark, marked, men, Mexico, mild, minimally, minimum, mortality, Notice, NW, NYHA, obsolescence, obtained, par, percent, personal, personally, physical, planned, PM, preceding, prime, proprietary, proven, quality, ranging, raw, realizable, realized, reclassified, reclassify, regenerate, rejection, remain, representing, repriced, request, requested, resolved, rest, satisfy, scarred, sell, Setting, settled, site, skeletal, sponsored, stating, Street, suffer, suffered, Suite, Sunrise, Systolic, Task, telephone, thigh, threshold, uncertainty, understand, unmet, utilized, view, wall, web, women, York

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

USRM similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Mike Tomas, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge, Bioheart, Inc.’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2014 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.




Date: May 9, 2014		/s/Mike Tomas
	Name:	Mike Tomas
		President and Chief Executive Officer Chief Financial Officer and Principal Accounting Officer

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.